Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy

Welin, Staffan; Sorbye, Halfdan; Sebjornsen, Sigrunn; Knappskog, Stian; Busch, Christian; Öberg, Kjell

doi:10.1002/cncr.26124

Public

Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy

Shared by NobleBlocks on Mar 28, 2011 • 12:00 AM UTC

Authors:

Staffan Welin

Halfdan Sorbye

Sigrunn Sebjornsen

Abstract

Abstract BACKGROUND: Patients with metastatic poorly differentiated endocrine carcinoma (PDEC) usually have a short survival. The chemotherapy combination of cisplatin and etoposide is frequently used as first‐line palliative chemotherapy. There are, however, no published studies concerning second‐l...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!